Connection

NORM LEHMAN to Humans

This is a "connection" page, showing publications NORM LEHMAN has written about Humans.
Connection Strength

0.514
  1. Frontal lobe intra-axial schwannoma harboring a CHD7::VGLL3 fusion and heterozygous TSC2 p.F1510del mutation in a young child. Mol Biol Rep. 2025 Jan 10; 52(1):112.
    View in: PubMed
    Score: 0.026
  2. The CNS-penetrating taxane drug TPI 287 potentiates antiglioma activity of the AURKA inhibitor alisertib in vivo. Cancer Chemother Pharmacol. 2023 02; 91(2):191-201.
    View in: PubMed
    Score: 0.022
  3. Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma. J Neurooncol. 2023 Feb; 161(3):425-439.
    View in: PubMed
    Score: 0.022
  4. Astroblastomas exhibit radial glia stem cell lineages and differential expression of imprinted and X-inactivation escape genes. Nat Commun. 2022 04 19; 13(1):2083.
    View in: PubMed
    Score: 0.021
  5. Aurora-A kinase is differentially expressed in the nucleus and cytoplasm in normal M?llerian epithelium and benign, borderline and malignant serous ovarian neoplasms. Diagn Pathol. 2021 Oct 27; 16(1):98.
    View in: PubMed
    Score: 0.020
  6. Cytotoxic synergy between alisertib and carboplatin versus alisertib and irinotecan are inversely dependent on MGMT levels in glioblastoma cells. J Neurooncol. 2019 Jun; 143(2):231-240.
    View in: PubMed
    Score: 0.017
  7. Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis. Acta Neuropathol Commun. 2019 03 15; 7(1):42.
    View in: PubMed
    Score: 0.017
  8. The CNS penetrating taxane TPI 287 and the AURKA inhibitor alisertib induce synergistic apoptosis in glioblastoma cells. J Neurooncol. 2018 May; 137(3):481-492.
    View in: PubMed
    Score: 0.016
  9. Cerebrospinal fluid dissemination of high-grade gliomas following boron neutron capture therapy occurs more frequently in the small cell subtype of IDH1R132H mutation-negative glioblastoma. J Neurooncol. 2017 05; 133(1):107-118.
    View in: PubMed
    Score: 0.015
  10. Molecular, clinical and neuropsychological study in 31 patients with Kabuki syndrome and KMT2D mutations. Clin Genet. 2017 Sep; 92(3):298-305.
    View in: PubMed
    Score: 0.015
  11. Case report: ACTH-secreting pituitary carcinoma metastatic to the liver in a patient with a history of atypical pituitary adenoma and Cushing's disease. Diagn Pathol. 2017 Apr 18; 12(1):34.
    View in: PubMed
    Score: 0.015
  12. Firm, non-tender mass in right breast ? worsening, nonproductive cough ? pleuritic pain ? Dx? J Fam Pract. 2017 01; 66(1):38-41.
    View in: PubMed
    Score: 0.015
  13. Morphological and molecular features of astroblastoma, including BRAFV600E mutations, suggest an ontological relationship to other cortical-based gliomas of children and young adults. Neuro Oncol. 2017 01; 19(1):31-42.
    View in: PubMed
    Score: 0.014
  14. Surgical Neuropathology of Focal Epilepsies: Textbook and Atlas. J Neuropathol Exp Neurol. 2016 Mar; 75(3):291.
    View in: PubMed
    Score: 0.014
  15. Primary Meningeal Pleomorphic Xanthoastrocytoma With Anaplastic Features: A Report of 2 Cases, One With BRAF(V600E) Mutation and Clinical Response to the BRAF Inhibitor Dabrafenib. J Neuropathol Exp Neurol. 2015 Oct; 74(10):960-9.
    View in: PubMed
    Score: 0.013
  16. Aurora-A inhibition offers a novel therapy effective against intracranial glioblastoma. Cancer Res. 2014 Oct 01; 74(19):5364-70.
    View in: PubMed
    Score: 0.012
  17. The selective Aurora-A kinase inhibitor MLN8237 (alisertib) potently inhibits proliferation of glioblastoma neurosphere tumor stem-like cells and potentiates the effects of temozolomide and ionizing radiation. Cancer Chemother Pharmacol. 2014 May; 73(5):983-90.
    View in: PubMed
    Score: 0.012
  18. Aurora A is differentially expressed in gliomas, is associated with patient survival in glioblastoma and is a potential chemotherapeutic target in gliomas. Cell Cycle. 2012 Feb 01; 11(3):489-502.
    View in: PubMed
    Score: 0.010
  19. Synoptic reporting for central nervous system tumors: has its time come? Arch Pathol Lab Med. 2011 Jun; 135(6):691-2.
    View in: PubMed
    Score: 0.010
  20. Intramedullary papillary ependymoma with choroid plexus differentiation and cerebrospinal fluid dissemination to the brain. J Neurosurg Pediatr. 2010 May; 5(5):511-7.
    View in: PubMed
    Score: 0.009
  21. The ubiquitin proteasome system in neuropathology. Acta Neuropathol. 2009 Sep; 118(3):329-47.
    View in: PubMed
    Score: 0.009
  22. Patterns of brain infiltration and secondary structure formation in supratentorial ependymal tumors. J Neuropathol Exp Neurol. 2008 Sep; 67(9):900-10.
    View in: PubMed
    Score: 0.008
  23. Central nervous system tumors with ependymal features: a broadened spectrum of primarily ependymal differentiation? J Neuropathol Exp Neurol. 2008 Mar; 67(3):177-88.
    View in: PubMed
    Score: 0.008
  24. Gliosarcoma with melanocytic differentiation. Acta Neuropathol. 2008 Mar; 115(3):357-61.
    View in: PubMed
    Score: 0.008
  25. Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors. Am J Pathol. 2007 May; 170(5):1793-805.
    View in: PubMed
    Score: 0.008
  26. Primary paraspinal leiomyosarcoma invading the cervical spinal canal successfully treated with surgery, radiotherapy, and chemotherapy. Case report. J Neurosurg Spine. 2007 May; 6(5):441-6.
    View in: PubMed
    Score: 0.008
  27. Overexpression of the anaphase promoting complex/cyclosome inhibitor Emi1 leads to tetraploidy and genomic instability of p53-deficient cells. Cell Cycle. 2006 Jul; 5(14):1569-73.
    View in: PubMed
    Score: 0.007
  28. Screening of tissue microarrays for ubiquitin proteasome system components in tumors. Methods Enzymol. 2005; 399:334-55.
    View in: PubMed
    Score: 0.006
  29. Malignant PEComa of the skull base. Am J Surg Pathol. 2004 Sep; 28(9):1230-2.
    View in: PubMed
    Score: 0.006
  30. Papillary tumor of the pineal region: analysis of DNA methylation profiles and clinical outcomes in 76 cases. Acta Neuropathol Commun. 2024 Jul 16; 12(1):117.
    View in: PubMed
    Score: 0.006
  31. Spatially Resolved Microglia/Macrophages in Recurrent Glioblastomas Overexpress Fatty Acid Metabolism and Phagocytic Genes. Curr Oncol. 2024 02 23; 31(3):1183-1194.
    View in: PubMed
    Score: 0.006
  32. MicroRNA regulation of the serine synthesis pathway in endocrine-resistant breast cancer cells. Endocr Relat Cancer. 2023 11 01; 30(11).
    View in: PubMed
    Score: 0.006
  33. Cortical ependymoma. A case report and review. Pediatr Neurosurg. 2003 Jul; 39(1):50-4.
    View in: PubMed
    Score: 0.006
  34. Synchronous subarachnoid drop metastases from a pituitary adenoma with multiple recurrences. Case report. J Neurosurg. 2003 May; 98(5):1120-3.
    View in: PubMed
    Score: 0.006
  35. Future potential of thymidylate synthase inhibitors in cancer therapy. Expert Opin Investig Drugs. 2002 Dec; 11(12):1775-87.
    View in: PubMed
    Score: 0.006
  36. Dural marginal zone lymphoma with massive amyloid deposition: rare low-grade primary central nervous system B-cell lymphoma. Case report. J Neurosurg. 2002 Feb; 96(2):368-72.
    View in: PubMed
    Score: 0.005
  37. HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells. Cancer Lett. 2021 10 10; 518:152-168.
    View in: PubMed
    Score: 0.005
  38. Modulation of RTX cytotoxicity by thymidine and dipyridamole in vitro: implications for chemotherapy. Cancer Chemother Pharmacol. 2000; 45(2):142-8.
    View in: PubMed
    Score: 0.005
  39. Pituitary carcinomas: review of the current literature and report of atypical case. Br J Neurosurg. 2020 Oct; 34(5):528-533.
    View in: PubMed
    Score: 0.004
  40. PTEN expression by an oncolytic herpesvirus directs T-cell mediated tumor clearance. Nat Commun. 2018 11 27; 9(1):5006.
    View in: PubMed
    Score: 0.004
  41. Pyruvate kinase M2 regulates homologous recombination-mediated DNA double-strand break repair. Cell Res. 2018 11; 28(11):1090-1102.
    View in: PubMed
    Score: 0.004
  42. Multiple lesions of skull and cervical spine: a rare presentation of unicameral bone cysts. BMJ Case Rep. 2018 Jul 15; 2018.
    View in: PubMed
    Score: 0.004
  43. IgG4-Related Disease: A New Etiology Underlying Diffuse Intracranial Dilating Vasculopathy. World Neurosurg. 2017 Nov; 107:1048.e15-1048.e20.
    View in: PubMed
    Score: 0.004
  44. NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors. Acta Neuropathol Commun. 2016 05 27; 4(1):55.
    View in: PubMed
    Score: 0.004
  45. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 2016 Jan 28; 164(3):550-63.
    View in: PubMed
    Score: 0.003
  46. A 59-Year-Old Man with History of Renal Transplantation. Brain Pathol. 2015 Nov; 25(6):788-9.
    View in: PubMed
    Score: 0.003
  47. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med. 2015 Jun 25; 372(26):2481-98.
    View in: PubMed
    Score: 0.003
  48. Changes in BAI1 and nestin expression are prognostic indicators for survival and metastases in breast cancer and provide opportunities for dual targeted therapies. Mol Cancer Ther. 2015 Jan; 14(1):307-14.
    View in: PubMed
    Score: 0.003
  49. Anaplastic papillary glioneuronal tumor with extraneural metastases. J Neuropathol Exp Neurol. 2014 May; 73(5):474-6.
    View in: PubMed
    Score: 0.003
  50. Radiation necrosis mimicking rapid intracranial progression of melanoma metastasis in two patients treated with vemurafenib. Melanoma Res. 2014 Apr; 24(2):172-6.
    View in: PubMed
    Score: 0.003
  51. Glioblastoma cell enrichment is critical for analysis of phosphorylated drug targets and proteomic-genomic correlations. Cancer Res. 2014 Feb 01; 74(3):818-28.
    View in: PubMed
    Score: 0.003
  52. Characterizing brain structures and remodeling after TBI based on information content, diffusion entropy. PLoS One. 2013; 8(10):e76343.
    View in: PubMed
    Score: 0.003
  53. Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class. Clin Cancer Res. 2013 Sep 15; 19(18):4951-60.
    View in: PubMed
    Score: 0.003
  54. Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system. Brain Pathol. 2013 Sep; 23(5):584-94.
    View in: PubMed
    Score: 0.003
  55. Differential expression of aurora-A kinase in T-cell lymphomas. Mod Pathol. 2013 May; 26(5):640-7.
    View in: PubMed
    Score: 0.003
  56. Predicting survival in glioblastomas using diffusion tensor imaging metrics. J Magn Reson Imaging. 2010 Oct; 32(4):788-95.
    View in: PubMed
    Score: 0.002
  57. Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo. Stem Cells. 2010 Feb; 28(2):181-90.
    View in: PubMed
    Score: 0.002
  58. Can permeability measurements add to blood volume measurements in differentiating tumefactive demyelinating lesions from high grade gliomas using perfusion CT? J Neurooncol. 2010 May; 97(3):383-8.
    View in: PubMed
    Score: 0.002
  59. Expression of CYP4A1 in U251 human glioma cell induces hyperproliferative phenotype in vitro and rapidly growing tumors in vivo. J Pharmacol Exp Ther. 2008 Oct; 327(1):10-9.
    View in: PubMed
    Score: 0.002
  60. GRP78 is overexpressed in glioblastomas and regulates glioma cell growth and apoptosis. Neuro Oncol. 2008 Jun; 10(3):236-43.
    View in: PubMed
    Score: 0.002
  61. Emi1 protein accumulation implicates misregulation of the anaphase promoting complex/cyclosome pathway in ovarian clear cell carcinoma. Mod Pathol. 2008 Apr; 21(4):445-54.
    View in: PubMed
    Score: 0.002
  62. Loss of Emi1-dependent anaphase-promoting complex/cyclosome inhibition deregulates E2F target expression and elicits DNA damage-induced senescence. Mol Cell Biol. 2007 Nov; 27(22):7955-65.
    View in: PubMed
    Score: 0.002
  63. Emi1 stably binds and inhibits the anaphase-promoting complex/cyclosome as a pseudosubstrate inhibitor. Genes Dev. 2006 Sep 01; 20(17):2410-20.
    View in: PubMed
    Score: 0.002
  64. Recessive dystrophic epidermolysis bullosa associated with mesangioproliferative glomerulonephritis and multifocal necrotizing leucoencephalopathy of the pons. Br J Dermatol. 2004 Dec; 151(6):1266-9.
    View in: PubMed
    Score: 0.002
  65. Early neonatal diagnosis of long-chain 3-hydroxyacyl coenzyme a dehydrogenase and mitochondrial trifunctional protein deficiencies. Mol Genet Metab. 2002 Feb; 75(2):120-7.
    View in: PubMed
    Score: 0.001
  66. 1H MRS in acute traumatic brain injury. J Magn Reson Imaging. 1998 Jul-Aug; 8(4):829-40.
    View in: PubMed
    Score: 0.001
  67. Cytotoxicity of antifolate inhibitors of thymidylate and purine synthesis to WiDr colonic carcinoma cells. Cancer Res. 1993 Dec 01; 53(23):5697-706.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.